Joung‐Liang Lan
Guangdong Medical College(CN)China Medical University(TW)Shaoxing University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Sichuan University(CN)West China Second University Hospital of Sichuan University(CN)The First People's Hospital of Shunde(CN)Institute for Rheumatic Diseases (Japan)(JP)Fuzhou Second Hospital(CN)China Medical University Hospital(TW)Fujian Provincial Hospital(CN)Northeast Forestry University(CN)Zhejiang University(CN)The University of Texas at Austin(US)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Immune Cell Function and Interaction, Inflammasome and immune disorders
Most-Cited Works
- → Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial(2018)354 cited
- Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.(2004)
- → Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy(2011)213 cited
- → Dehydroepiandrosterone treatment of women with mild‐to‐moderate systemic lupus erythematosus: A multicenter randomized, double‐blind, placebo‐controlled trial(2002)163 cited
- → Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study(2015)130 cited
- → An Association of Gut Microbiota with Different Phenotypes in Chinese Patients with Rheumatoid Arthritis(2019)